Compare Recursion Pharmaceuticals Inc (RXRX) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Recursion Pharmaceuticals Inc trades at $3.3 (market cap $1.81B), while Direxion Daily Semiconductor Bull 3X Shares trades at $143.27. The key difference: Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | SOXL | |
|---|---|---|
Market Cap | $1.81B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $6.79 | $300.77 |
52-Week Low | $2.84 | $24.91 |
Enterprise Value | $1.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $3.295, up 0.15% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported a Q2 2026 earnings miss with revenue declining year-over-year, while maintaining a strong cash position from financing activities. Recent news highlights participation in investor conferences and partnership advancements with Genentech.
Outlook remains speculative with high revenue growth potential from AI-driven drug discovery partnerships, but significant risks persist due to deep losses and negative margins. Analyst sentiment is mixed with a 40% buy rating, emphasizing the stock's high-risk, high-reward profile dependent on future clinical and commercial milestones.
SOXL, the Direxion Daily Semiconductor Bull 3X Shares ETF, surged 13.02% to $146.92 amid renewed semiconductor sector optimism. The leveraged ETF remains in a technical bearish trend despite the recent rally, with moving averages signaling continued downward pressure. Recent news highlights significant government semiconductor funding and AI-driven demand catalysts, though the fund has experienced extreme volatility, dropping over 60% from its peak earlier this year before this rebound.
The outlook remains volatile with leveraged exposure amplifying both gains and losses. Investment opportunity exists for aggressive investors betting on sustained semiconductor recovery and AI infrastructure spending, but risks include extreme volatility decay, sector concentration, and macroeconomic sensitivity. The current technical setup suggests cautious entry near support levels may offer better risk-reward positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
